BSG Response to Consultation on the Government's Alcohol Strategy
Thursday, 07 February 2013 17:52
Tom Smith, BSG Chief Executive
The British Society of Gastroenterology is continuing to lobby in the interests of our members, and patients, across gastroenterology and hepatology. As I am sure you are aware, the Government is currently consulting on their Alcohol Strategy which includes provision for a minimum unit price for alcohol of 45p. The BSG is working closely with partners in the Alcohol Health Alliance (AHA) to ensure that this minimum unit price is brought into action and that it is set at the more effective price of 50p. This is a significant moment in the push for measures to deal with the increasing problems that alcohol poses to the nation's health and we must seize on the opportunity to demonstrate the widespread support of health professionals for these measures. The BSG & AHA have submitted their responses. (The BSG response may be viewed via the link below).
- View BSG response [ 650 kb ]
NICE Alcohol Evidence Update 2013
Thursday, 07 February 2013 16:34
'Alcohol use disorders: harmful drinking and alcohol dependence Evidence Update January 2013'
NICE has released a summary of selected new evidence relevant to its clinical guideline 'Alcohol use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence' (2011)
Evidence Updates provide a summary of selected new evidence published since the literature search was last conducted for the accredited guidance they relate to. They reduce the need for individuals, managers and commissioners to search for new evidence. Evidence Updates highlight key points from the new evidence and provide a commentary describing its strengths and weaknesses. They also indicate whether the new evidence may have a potential impact on current guidance. For contextual information, this Evidence Update should be read in conjunction with the relevant clinical guideline, available from the NHS Evidence topic page for alcohol.
- Download evidence update [ 394 kb ]
New study to examine thre role of vitamin D in the progression of paediatric NAFLD
Monday, 26 November 2012 08:19
Children's Liver Disease Foundation (CLDF), the UK’s leading charity fighting childhood liver disease, is to fund a PhD student fellowship at the University of Surrey which will look at the role of vitamin D in the progression of paediatric non-alcoholic fatty liver disease (NAFLD), now recognised as the most common cause of childhood liver disease in the UK.
The £74,500 award will fund a three year study, to be led by Dr Bernadette Moore, a lecturer in molecular nutrition at the University, who will be working in collaboration with Kings College Hospital Paediatric Liver Clinic.
"We are thrilled that CLDF have agreed to fund this project which will enable us to find out more about a disease which is affecting increasing numbers of UK children," commented Dr Moore. "The incidence of paediatric NAFLD has risen sharply in past three decades, affecting an estimated 3–9% of all children and up to 70% of obese children."
"Whilst we know that people in the UK have low level vitamin D status during the winter due to the lack of sunlight, children with fatty liver disease have been shown to have particularly low levels and this deficiency is associated with more severe liver disease. This project will examine the diet and specific genes that can affect vitamin D levels in UK children with liver disease."
Burden of Liver Disease and Inequalities in the North West of England
Wednesday, 19 September 2012 13:12
Liver disease causes approximately 2% of all deaths in England. While other major causes of death are falling, the number of people who die from liver disease is rising and younger age groups are disproportionately affected.
This report collates routinely available data on the burden of liver disease and describes its relationship with inequalities. We hope that it will be a useful resource for Directors of Public Health, health and wellbeing boards, commissioners and providers of services as well as others involved in or with an interest in liver disease. We realise that there are gaps in the information where data are not routinely available. However, we hope the report serves as an important baseline to measure progress on reducing ill health caused by liver disease.
Survey of Hepatitis C Services in Prisons in England
Tuesday, 24 July 2012 08:39
The first dedicated survey of hepatitis C services in prisons in England shows that diagnosis and treatment for chronic hepatitis C infection is available to prisoners in most prisons in England, but that care models available vary between in-reach service and out-reach based services.
The aim of the survey was to collect basic information on what type of services are provided in prisons for the diagnosis, treatment and follow-up of prisoners infected by hepatitis C. There are some positive indications emerging from the survey, the most important one being that hepatitis C diagnostic services are now being offered in all prisons except one. A previous generic survey carried out in 2007 showed only two thirds of prisons testing.
The results of this survey details useful information for policy makers, commissioners and service providers on models of good practice for provision of diagnosis, treatment and care of people living with hepatitis C infection in prisons in England.
Page 2 of 3